Long Focus Capital Management, LLC Iovance Biotherapeutics, Inc. Transaction History
Long Focus Capital Management, LLC
- $2.69 Billion
- Q3 2025
A detailed history of Long Focus Capital Management, LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Long Focus Capital Management, LLC holds 9,116,507 shares of IOVA stock, worth $22.5 Million. This represents 0.74% of its overall portfolio holdings.
Number of Shares
9,116,507
Previous 11,820,000
22.87%
Holding current value
$22.5 Million
Previous $20.3 Million
2.7%
% of portfolio
0.74%
Previous 0.94%
Shares
17 transactions
Others Institutions Holding IOVA
# of Institutions
291Shares Held
219MCall Options Held
2.41MPut Options Held
1.7M-
Mhr Fund Management LLC New York, NY29MShares$71.5 Million10.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.1MShares$59.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$52.4 Million0.0% of portfolio
-
State Street Corp Boston, MA13.3MShares$32.9 Million0.0% of portfolio
-
Invenomic Capital Management LP Boston, MA10.5MShares$26 Million1.15% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $390M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...